Innovation Opportunity and Challenge of Standardization in Response to COVID-19 Pandemic and the Socio-Economic Impact: A Case Study in Indonesia
Abstract
:1. Introduction
2. Literature Review on Pandemics and the Role of Standardization
3. Methods
4. Results and Discussion
4.1. Role and Challenges of Standardization, Conformity Assessment, and Metrology
4.1.1. Role and Challenges of Standard Formulation and Development
4.1.2. Role and Change of Business Process of Accreditation and Conformity Assessment
4.1.3. Role and Change of Business Process of Metrology and Calibration
4.2. Challenges of Innovation for Medical Device, Diagnostic, and Therapy
4.3. Challenges of Standardization Regarding the Socio-Economic Impacts
5. Conclusions and Recommendation
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Finsterwalder, J.; Kuppelwieser, V.G. Equilibrating resources and challenges during crises: A framework for service ecosystem wellbeing. J. Serv. Manag. 2020. ahead-of-print. [Google Scholar] [CrossRef]
- WHO. Coronavirus Disease (COVID-19) Weekly Epidemiological Update and Weekly Operational; World Health Organization: Geneva, Switzerland, 2021. [Google Scholar]
- MoF (The Ministry of Finance of Republic Indonesia). Macroeconomic Framework (KEM) and Principles of Fiscal Policy (PPKF) in 2021; The Ministry of Finance of Rep: Jakarta, Indonesia, 2020. Available online: https://www.kemenkeu.go.id/publikasi/berita/kem-ppkf-tahun-2021-skenario-apbn-menghadapi-tantangan-tahun-depan (accessed on 25 September 2020).
- Muhyiddin, M.; Nugroho, H. A Year of COVID-19: A Long Road to Recovery and Acceleration of Indonesia’s Development. Indones. J. Dev. Plan. 2021, 5, 1–19. [Google Scholar] [CrossRef]
- MoLHR (The Ministry of Law and Human Rights of Rep. Indonesia). President Regulation of Rep. Indonesia Regulation No 122, Plan Update for 2021; Accelerating Economic Recovery and Social Reform; The Ministry of Law and Human Rights of Rep. Indonesia: Jakarta, Indonesia, 2021.
- Cachanosky, N.; Cutsinger, B.; Hogan, T.; Luther, W.; Salter, A. The Federal Reserve’s response to the COVID-19 contraction: An initial appraisal. South. Econ. J. 2021, 87, 1152–1174. [Google Scholar] [CrossRef]
- Zaremba, A.; Kizys, R.; Aharone, D.Y. Volatility in International Sovereign Bond Markets: The role of government policy responses to the COVID-19 pandemic. Financ. Res. Lett. 2021, 102011. [Google Scholar] [CrossRef]
- Prasetya, B. The Role of Standardization and Conformity Assessment for the Supporting of Acceleration to Recovery of Pandemic COVID-19. In Proceedings of the PPI (Annual Meeting and Presentation of Standardization). (Vol1) 2020, Online, 4 October 2020; pp. 1–10. [Google Scholar]
- Zutshi, A.; Mendy, J.; Sharma, G.S.; Asha Thomas, A.; Sarker, T. From Challenges to Creativity: Enhancing SMEs’ Resilience in the Context of COVID-19. Sustainability 2021, 13, 6542. [Google Scholar] [CrossRef]
- Cortez, R.M.; Johnston, W.J. The Coronavirus crisis in B2B settings: Crisis uniqueness and managerial implications based on social exchange theory. Ind. Mark. Manag. 2020, 88, 125–135. [Google Scholar] [CrossRef]
- Kabadayi, S.; O’Connor, G.E.; Tuzovic, S. Viewpoint: The impact of coronavirus on service ecosystems as service mega-disruptions. J. Serv. Mark. 2020, 34, 809–817. [Google Scholar] [CrossRef]
- Sheth, J. Impact of COVID-19 on consumer behavior: Will the old habits return or die? J. Bus. Res. 2020, 117, 280–283. [Google Scholar] [CrossRef]
- Heinonen, K.; Strandvik, T. Reframing service innovation: COVID-19 as a catalyst for imposed service innovation. J. Serv. Manag. 2021, 32, 101–112. [Google Scholar] [CrossRef]
- MoF (The Ministry of Finance of Republic Indonesia). Pandemic, Green Economy Transformation Moment. Available online: https://www.kemenkeu.go.id/publikasi/artikel-dan-opini/pandemi-momentum-transformasi-green-economy (accessed on 23 September 2021).
- Dhama, K.; Khan, S.; Tiwari, R.; Sircar, S.; Sudipta Bhat, S.; Malik, Y.S.; Singh, K.P.; Chaicumpa, W.; Bonilla-Aldana, D.K.; Rodriguez-Morales, A.J. Coronavirus Disease 2019–COVID-19. Clin. Microbiol. Rev. 2020, 33, e00028-20. [Google Scholar] [CrossRef]
- Dong, E.; Du, H.; Gardner, L. An interactive web-based dashboard to track COVID-19 in real-time. Lancet Infect. Dis. 2020, 20, 533–534. [Google Scholar] [CrossRef]
- Carfi, A.; Bernabei, R.; Landi, F. Gemelli Against COVID-19. Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. J. Am. Med. Assoc. 2020, 324, 603–605. [Google Scholar] [CrossRef] [PubMed]
- Tang, N.; Li, D.; Wang, X.; Sun, Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 2020, 18, 844–847. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nalbandian, A.; Sehgal, K.; Grupta, A.; Madhavan, M.V.; McGroder, C.; Stevens, J.S.; Cook, J.R.; Norvig, A.; Shalev, D.; Sehrawat, T.S.; et al. Post-acute COVID-19 syndrome. Nat. Med. 2021, 27, 601–615. Available online: www.nature.com/naturemedicine (accessed on 23 September 2021). [CrossRef]
- Wang, C.; Horby, P.W.; Hayden, F.G.; Gao, G.F. A novel coronavirus outbreak of global health concern. Lancet 2020, 395, 470–473. [Google Scholar] [CrossRef] [Green Version]
- Farmer, P. Ebola, the Spanish flu, and the memory of disease. Crit. Inq. 2019, 46, 56–70. [Google Scholar] [CrossRef]
- Du, N.; Yang, X.X.; Yang, L.; Zeng, Y.H.; Zou, S.M.; Bo, H.; Shu, Y.L. Review on the etiological property of 1957 Asian flu virus (H2N2). Bing Du Xue Bao Chin. J. Virol. 2009, 25, 12–16. [Google Scholar]
- Chen, J. Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses. Microbes Infect. 2020, 22, 69–71. [Google Scholar] [CrossRef]
- Jarus, O. 20 of the Worst Epidemics and Pandemics in History. 2020. Available online: https://www.livescience.com/worst-epidemics-and-pandemics-in-history.html (accessed on 25 September 2021).
- Starling, A. Plague, SARS, and the Story of Medicine in Hong Kong; HK University Press: Hong Kong, 2006; p. 55. ISBN 978-962-209. [Google Scholar]
- WHO. Fact Sheet hiv/aid. 2021. Available online: https://www.who.int/news-room/fact-sheets/detail/hiv-aids (accessed on 23 September 2021).
- WHO. Coronavirus Disease (COVID-19) Pandemic. 2021. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019? (accessed on 25 September 2021).
- AVMA (American Veterinary Medical Association). Guidelines for PPE Use as Veterinary Facilities Resume Providing Normal Services. 2020. Available online: https://www.avma.org/resources-tools/animal-health-and-welfare/COVID-19/guidelines-ppe-COVID-19-pandemic-demand-exceeds (accessed on 25 September 2021).
- Sallam, M. COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates. Vaccines 2021, 9, 160. [Google Scholar] [CrossRef]
- Folegatti, P.M.; Ewer, K.J.; Aley, P.K.; Angus, B.; Becker, S.; Belij-Rammerstorfer, S.; Bellamy, D.; Bibi, S.; Bittaye, M.; Clutterbuck, E.A.; et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: A preliminary report of a phase 1/2, single-blind, randomized controlled trial. Lancet 2020, 396, 467–478. [Google Scholar] [CrossRef]
- Jackson, L.A.; Anderson, E.J.; Rouphael, N.G.; Roberts, P.C.; Makhene, M.; Coler, R.N.; McCullough, M.P.; Chappell, J.D.; Denison, M.R.; Stevens, L.J.; et al. An mRNA vaccine against SARS-CoV-2—Preliminary report. N. Engl. J. Med. 2020, 383, 1920–1931. [Google Scholar] [CrossRef]
- Wang, C.; Wang, Z.; Wang, G.; Lau, J.Y.-N.; Zhang, K.; Le, W. COVID-19 in early 2021: Current status and looking forward. Signal Transduct. Target Ther. 2021, 6, 114. [Google Scholar] [CrossRef]
- Wold Bank. Global Recovery Strong but Uneven as Many Developing Countries Struggle with the Pandemic’s Lasting Effects. 2021. Available online: https://www.worldbank.org/en/news/press-release/2021/06/08/world-bank-global-economic-prospects-2021 (accessed on 23 September 2021).
- Farzanegan, M.R.; Feizi, M.; Gholipour, H.F. Globalization and the Outbreak of COVID-19: An Empirical Analysis. Risk Financ. Manag. 2021, 14, 105. [Google Scholar] [CrossRef]
- BSN (National Agency for Standardization of Indonesia). Strategic Plan 2020–2024. National Agency for Standardization of Indonesia. 2020. Available online: https://www.bsn.go.id/main/download/index/930 (accessed on 23 September 2021).
- UNIDO. Quality and Standards and Their Role in Responding to COVID-19. 2020. Available online: https://www.unido.org/sites/default/files/files/2020-04/ (accessed on 3 July 2021).
- Lee, K.H.; Noh, J.; Khim, J.S. The Blue Economy and the United Nations sustainable development goals: Challenges and opportunities. Environ. Int. 2020, 137, 105528. [Google Scholar] [CrossRef] [PubMed]
- ITC (International Trade Center). COVID-19: The Great Lockdown and its Impact on Small Business. 2020. Available online: https://www.intracen.org/SMEOutlook/ (accessed on 16 April 2021).
- ISO (International Organization for Standardization). Standard for Occupational Health and Safety Management System, ISO 45001. 2021. Available online: https://www.iso.org/standards.html (accessed on 3 July 2021).
- ITC (International Trade Center). SME Competitiveness Outlook 2021: Empowering the Green Recovery. 2021. Available online: https://www.intracen.org/uploadedFiles/intracenorg/Content/Publications/ITC_SMECO-2021.pdf (accessed on 23 September 2021).
- WTO (World Trade Organization). The TBT Committee’s Six Principles for the Development of International Standards: Are They Still Relevant? 2020. Available online: https://www.wto.org/english/tratop_e/tbt_e/tbt_six_principles_e.htm (accessed on 3 July 2021).
- BSN (National Agency for Standardization). Report on Strategic Plan. 2021. Available online: https://bsn.go.id/main/berita/detail/11325/28-standar-nasional-terkait-covid-19 (accessed on 23 September 2021).
- KAN (National Accreditation Committee). Directory of Conformity Assessment Institution. 2021. Available online: http://www.kan.or.id/index.php/documents/terakreditasi (accessed on 23 September 2021).
- ISO (International Organization for Standardization). CASCO/STAR COVID-19 Survey. May 2020. Available online: https://www.iso.org/files/live/sites/isoorg/files/standards/conformity_assessment/casco/CASCO%20STAR%20COVID-19%20survey%202020.pdf (accessed on 23 September 2021).
- BIPM (Bureau International des Poids et Mesures; The International Bureau of Weights and Measures. JCTLM Newsletter COVID-19 Special Issue. 2020. Available online: https://www.bipm.org/documents/20126/42834057/JCTLM-Newsletter-2020-COVID-19.pdf/a025477a-dbd6-40ed-e142-81a3382272b3 (accessed on 23 September 2021).
- BRIN (National Agency for Research and Innovation of Indonesia). COVID-19 Research and Innovation Consortium. 2020. Available online: https://www.brin.go.id/wp-content/uploads/2020/08/Katalog-Produk-Konsorsium-COVID-19-26082020.pdf (accessed on 27 September 2021).
- Dutta, S.; Lanvin, B.; Leon, L.R.; Wunch-Vincent, S. Global Innovation Index 2021. Tracking Innovation through the COVID-19 Crisis. 2020. Available online: https://www.wipo.int/edocs/pubdocs/en/wipo_pub_gii_2021.pdf (accessed on 27 September 2021).
- Utomo, M.N.; Ariska, I.; Pratiwi, S.R.; Kaujan, K. Strategies for Maintaining SMEs Performance During Covid-19 Pandemic. Int. J. Soc. Sci. Bus. 2021, 5, 34–43. [Google Scholar]
- Ramful, K.; Kieck, E. Standards: Life Support for Small Businesses during COVID-19. 2020. Available online: https://www.intracen.org/covid19/Blog/Standards-Life-support-for-small-businesses-during-COVID-19 (accessed on 20 September 2021).
- Creswell, J.W. Qualitative Inquiry and Research Design: Choosing among Five Approaches, 3rd ed.; SAGE Publications, Inc.: New York, NY, USA, 2013; p. 442. [Google Scholar]
Periods | Name | Type | Death | Reference |
---|---|---|---|---|
1918–1919 | Spanish Flu | H1N1 Virus | More than 50 M | [21] |
1957–1958 | Asian Flu | H2N2 Virus | 1.15 M | [22] |
1968–1970 | Hong Kong Flu | H3N2 | 1 M | [23,24,25] |
1981–present | HIV/AIDS | Virus HIV | 32 M (estimated March 2020) | [26] |
2019–present | COVID-19 | Coronavirus | 4.8 M per 5 Oct 2021 | [27] |
No | Hierarchy Control | Goals | Effectiveness |
---|---|---|---|
1 | PPE (personal protective equipment) | Protect the worker: people with PPE | Less effective |
2 | Administrative control | Change the people at work | |
3 | Engineering control | Isolate people from the hazard | |
4 | Substitution | Replace the hazard | |
5 | Elimination | Physically remove the hazard | Most effective |
Policy | Standards | Accreditation | Metrology | Conformity Assessment | Enterprises |
---|---|---|---|---|---|
Quality Policy Laboratory Policy | Medical equipment/protective gear (medical), laboratory standards, business continuity, emergency management, quality control techniques, health, safety and hygiene, sanitation and waste management | Attestation of technical competence International/mutual recognition | Accurate measurement for reliable testing, quality and accuracy of laboratory tests | Health care facilities and testing laboratories, quality control of medical supplies, medical testing for COVID-19, development of new medication/vaccines, market surveillance and inspection | Shift to produce medical equipment/protective gear, business continuity, enhanced sanity protocols, avoid disruption of essential inputs to global value chains |
No | Data Collection | Subject, Related Topics (Number) | Data Validation | Location |
---|---|---|---|---|
1 | Observation Webinar Talk show FDG Press release | Standard development (7) Accreditation and conformity assessment (9) Metrology (3) Innovation (15) Regulation (12) | Direct asking of questions | Jakarta Bogor Tangerang |
2 | Interviews with role model from selected SME | SMEs (21) with following products (medical equipment and device, cloth, food, batik machinery, sport equipment) | Government officer from BSN and the Ministry (industry, trade, agriculture, maritime and fisheries) | Tangerang Bogor Makassar Palembang East Java DIY |
3 | Secondary data (journal, official report, other publication) | COVID-19 pandemic, standardization, accreditation, metrology, conformity assessment, economic and business, regulatory and policies, innovation | Through comparative analysis of article in journals and other publications | - |
No | ISO Standard | Thematic Subject of Standard |
---|---|---|
1 | ISO/PAS 45005:2020 | Occupational health and safety management—General guidelines for safe working during the COVID-19 pandemic |
2 | SO 13688:2013/AMD 1:2021 | Protective clothing—General requirements—AMENDMENT 1 |
3 | ISO 80601-2-12:2020 | Medical electrical equipment—Part 2–12: Particular requirements for basic safety and essential performance of critical care ventilators |
4 | ISO 20395:2019 | Biotechnology—Requirements for evaluating the performance of quantification methods for nucleic acid target sequences—qPCR and dPCR |
5 | ISO 80601-2-74:2017 | Medical electrical equipment—Part 2–74: Particular requirements for basic safety and essential performance of respiratory humidifying equipment |
6 | ISO 80601-2-79:2018 | Medical electrical equipment—Part 2–79: Particular requirements for basic safety and essential performance of ventilatory support equipment for ventilatory impairment |
7 | ISO 80601-2-70:2020 | Medical electrical equipment—Part 2–70: Particular requirements for basic safety and essential performance of sleep apnoea breathing therapy equipment |
8 | ISO 80601-2-84:2020 | Medical electrical equipment—Part 2–84: Particular requirements for the basic safety and essential performance of ventilators for the emergency medical services environment |
9 | ISO 10993-1:2018 | Biological evaluation of medical devices—Part 1: Evaluation and testing within a risk management process |
10 | ISO/TS 16976-8:2013 | Respiratory protective devices—Human factors—Part 8: Ergonomic factors |
11 | ISO 18562-1:2017 | Biocompatibility evaluation of breathing gas pathways in healthcare applications—Part 1: Evaluation and testing within a risk management process |
12 | ISO 18562-2:2017 | Biocompatibility evaluation of breathing gas pathways in healthcare applications—Part 2: Tests for emissions of particulate matter |
13 | ISO 18562-3:2017 | Biocompatibility evaluation of breathing gas pathways in healthcare applications—Part 3: Tests for emissions of volatile organic compounds (VOCs) |
14 | SO 18562-4:2017 | Biocompatibility evaluation of breathing gas pathways in healthcare applications—Part 4: Tests for leachables in condensate |
15 | ISO 80601-2-80:2018 | Medical electrical equipment—Part 2–80: Particular requirements for basic safety and essential performance of ventilatory support equipment for ventilatory insufficiency |
16 | ISO 19223:2019 | Lung ventilators and related equipment—Vocabulary and semantics |
No | Preventing of Spreading | Handling Support | Screening and Diagnostics | Medicinal and Therapeutic |
---|---|---|---|---|
1 | Rapid diagnostic test microchip | RAISA TIARA Robot | Viral Transport Medium | Convalescence Serum |
2 | Rapid Diagnostic Test RI-GHA | RAISA BCL Robot | VTM (Viral Transport Medium) | Herbal Flu Imboost |
3 | Real Time PCR Test Kit BioCov-19 | Decontamination Robot | Plasmid Eijkman Control for COVID-19 (pECoC-19) | Quinine Pill |
4 | Autonomous UVC Mobile Robot | Smart Syringe Pump | Robot RAISA | Anti-COVID-19 Serum |
5 | OST D | Emergency Ventilators | Mobile Laboratory BSL-2 | Mesenchymal Stem Cell |
6 | Herbal Hand Sanitizer | Powered Air Purifying Respirator | Flocked Swab | Convalescence Serum |
7 | Insert Mask | Ventilator Vent-I | Sequence Protein S SARS CoV 2 | Herbal Flu Boost |
8 | Air Cleaner | Venindo V01 | AI based Medical Imaging System | Quinine Pill |
9 | Portable Air Purifier | Venindo R03 | Smart Biosafety Swab Chamber (BCL-UGM) | Anti-COVID-19 Serum |
10 | Touchless Mobile Handwasher | GLP-HFNC-01 (High Flow Nasal Cannula) | GAMA Swab Sampling Chamber | |
11 | N95 Mask Sterilization Box | Cov-Watch | Platform Digital (Cared+) | |
12 | HR COMED | Aero Dental Suction Unit | Radiograph Sinar X-Digital | |
13 | APD: Lab-Scale Natural Nano Fibers | Smart Telemedicine Robot “Win-MTA” | Swabidarity | |
14 | PPE Level 3 and 4 | Servant Robot | PCR Isothermal Lamp 2 | |
15 | H2 (Health | Robot Representative Doctor (Doper) | Electronic Nose (E-Nose) | |
16 | Isothermal | Low-Cost Mobile Ventilators | WGS (Whole Genome Sequencing) SARS-CoV-2 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Prasetya, B.; Restu Wahono, D.; Yopi; Prasetya, C. Innovation Opportunity and Challenge of Standardization in Response to COVID-19 Pandemic and the Socio-Economic Impact: A Case Study in Indonesia. Standards 2022, 2, 66-82. https://doi.org/10.3390/standards2010006
Prasetya B, Restu Wahono D, Yopi, Prasetya C. Innovation Opportunity and Challenge of Standardization in Response to COVID-19 Pandemic and the Socio-Economic Impact: A Case Study in Indonesia. Standards. 2022; 2(1):66-82. https://doi.org/10.3390/standards2010006
Chicago/Turabian StylePrasetya, Bambang, Daryono Restu Wahono, Yopi, and Candraditya Prasetya. 2022. "Innovation Opportunity and Challenge of Standardization in Response to COVID-19 Pandemic and the Socio-Economic Impact: A Case Study in Indonesia" Standards 2, no. 1: 66-82. https://doi.org/10.3390/standards2010006
APA StylePrasetya, B., Restu Wahono, D., Yopi, & Prasetya, C. (2022). Innovation Opportunity and Challenge of Standardization in Response to COVID-19 Pandemic and the Socio-Economic Impact: A Case Study in Indonesia. Standards, 2(1), 66-82. https://doi.org/10.3390/standards2010006